<DOC>
	<DOCNO>NCT01981057</DOCNO>
	<brief_summary>The aim prospective noninterventional study evaluate clinical application Numeta® preterm infant critically ill neonate comparison individualize prescribed parenteral nutrition . With prescription software Cato-PAN® ( Cato software solution ) exact valid prescription order parenteral nutrition solution premature infant compare . Each PN solution prescribe individually well Numeta . Prescriptions mirror respect weight , venous approach , total volume amount enteral feeding , 24h medication flip vice versa . The key nutrient calculate Numeta prescription protein . The result PN prescription compare other/ESPGHAN recommendation . The investigator hypothesize nutrimental content Numeta prescription equal individually prescribe .parenteral nutrition solution</brief_summary>
	<brief_title>Clinical Experience With Numeta</brief_title>
	<detailed_description />
	<criteria>preterm infant &lt; 37 week gestational age parenteral nutrition therapy hypersensitivity egg , soy peanut protein active substance congenital abnormality amino acid metabolism pathogenically elevate plasma concentration sodium , potassium , magnesium , calcium and/or phosphorous severe hyperglycemia severe hyperlipidemia severe disorder lipid metabolism characterize hypertriglyceridemia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>parenteral nutrition</keyword>
	<keyword>Numeta</keyword>
	<keyword>prescription software Cato Pan</keyword>
</DOC>